Design and Analysis of Palliative Care Trials Evaluating Early Interventions
评估早期干预的姑息治疗试验的设计和分析
基本信息
- 批准号:8858688
- 负责人:
- 金额:$ 7.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-03 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdoptionAdvanced Malignant NeoplasmAffectCaringCessation of lifeClinical TrialsComplexDataData SetDependenceEarly InterventionEpidemiologyEvaluationFutureGoalsGrantHealthHospitalsInstitutionInterventionIntervention StudiesJointsLifeMeasurementMethodologyMethodsModelingOutcomePainPain DisorderPain ResearchPain qualityPalliative CarePatientsPhaseProceduresProcessQuality of lifeRandomizedReportingRequest for ProposalsResearch DesignResearch PersonnelSample SizeStandardizationStatistical MethodsSupportive careSymptomsTechniquesTerminal DiseaseTimeWaiting Listsarmbasedepressive symptomsdesignend of lifeimprovedinnovationinsightjoint functionnovelpreventprimary outcomeprogramsresearch studystandard caretime intervaltreatment effecttrial design
项目摘要
DESCRIPTION (provided by applicant): Palliative care focuses on helping relieve pain and prevent the suffering of patients, especially those patients facing advanced cancer and other life-threatening illnesses. More than 80% of large U.S. hospitals have or currently are developing palliative care programs. Although the main goal of palliative care is to improve patient outcomes such as pain and quality of life (QoL), studies have demonstrated that palliative care may also affect survival. Evaluation and improvement of palliative care programs is a primary goal for these research studies. To accomplish this goal, new statistical methods are needed, ranging from improved definition of processes and interventions to standardization of outcomes and improved statistical analysis. In this project, we propose to develop novel methods for the design and analysis of palliative care research studies that have the potential to increase scientific rigor and to fully utilize the valuable data that these trials
generate. One of the major statistical issues raised in palliative care studies regards the interplay and tradeoffs between the quality and duration of life, commonly used as primary outcomes. It has been widely noted that patient outcomes worsen at the end of life for patients with advanced cancer. This suggests dependence between survival and longitudinal measurements of patient outcomes. Palliative care intervention studies have reinforced this hypothesis by showing gains in survival and QoL and symptoms including pain. However, this dependence has not been taken into account in analyzing or designing palliative care clinical trials. We have recently developed a method for jointly modeling longitudinal outcomes and survival in palliative care studies using a novel terminal decline model (TDM) where outcomes are modeled in terms of time from death on a retrospective time scale. Randomized "early intervention" or "fast-track" trials (also sometimes called delayed intervention, delayed-start, or
wait list designs) have been proposed as an alternative to traditional RCTs comparing palliative care interventions to non-palliative or other supportive care groups. However, many issues remain with respect to implementing such designs. We propose to study this trial design and more general "stepped wedge" designs in the context of TDMs. Specifically, we will address methods for estimating treatment effects and for choosing optimal design features such as overall sample size and the optimal timing of interventions..
描述(由申请人提供):姑息治疗的重点是帮助减轻疼痛,防止患者的痛苦,特别是那些面临晚期癌症和其他危及生命的疾病的患者。超过80%的美国大型医院已经或正在开发姑息治疗项目。虽然姑息治疗的主要目标是改善患者的结局,如疼痛和生活质量(QoL),但研究表明姑息治疗也可能影响生存率。评估和改善姑息治疗计划是这些研究的主要目标。为了实现这一目标,需要新的统计方法,从改进定义, (c)将各种程序和干预措施纳入成果标准化和改进统计分析。在这个项目中,我们建议开发新的方法来设计和分析姑息治疗研究,这些研究有可能增加科学的严谨性,并充分利用这些试验所提供的有价值的数据。
生成.姑息治疗研究中提出的主要统计问题之一是生命质量和持续时间之间的相互作用和权衡,通常用作主要结局。人们广泛注意到,晚期癌症患者在生命结束时的患者结局会恶化。这表明生存率和患者结局的纵向测量之间存在依赖性。姑息治疗干预研究通过显示生存率和生活质量以及包括疼痛在内的症状的改善,强化了这一假设。然而,在分析或设计姑息治疗临床试验时没有考虑到这种依赖性。我们最近开发了一种方法,用于联合建模的纵向结果和生存的姑息治疗研究中使用一种新的终端下降模型(TDM),结果是从死亡的时间在回顾性时间尺度上建模。 随机"早期干预"或"快速通道"试验(有时也称为延迟干预、延迟开始或
等待名单设计)已被提议作为传统RCT的替代方案,将姑息治疗干预与非姑息治疗或其他支持性治疗组进行比较。然而,关于实现这样的设计仍然存在许多问题。我们建议在TDM的背景下研究这种试验设计和更一般的"阶梯楔"设计。具体来说,我们将讨论估计治疗效果和选择最佳设计特征,如总样本量和最佳干预时机的方法。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Assessing Preparatory Grief in Advanced Cancer Patients as an Independent Predictor of Distress in an American Population.
评估晚期癌症患者的预备性悲伤作为美国人群痛苦的独立预测因子。
- DOI:10.1089/jpm.2016.0136
- 发表时间:2017
- 期刊:
- 影响因子:2.8
- 作者:Vergo,MaxwellT;Whyman,Jeremy;Li,Zhigang;Kestel,Jeanne;James,SpencerL;Rector,Christopher;Salsman,JohnM
- 通讯作者:Salsman,JohnM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhigang Li其他文献
Zhigang Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhigang Li', 18)}}的其他基金
Data Science Core: Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection
数据科学核心:改善 HIV 感染者肠脑轴酒精相关合并症的干预措施
- 批准号:
10682453 - 财政年份:2021
- 资助金额:
$ 7.86万 - 项目类别:
Data Science Core: Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection
数据科学核心:改善 HIV 感染者肠脑轴酒精相关合并症的干预措施
- 批准号:
10304324 - 财政年份:2021
- 资助金额:
$ 7.86万 - 项目类别:
Mediation Analysis Methods to Model Human Microbiome Mediating Disease-Leading Causal Pathways in Children
用于模拟人类微生物组介导儿童疾病主导因果路径的中介分析方法
- 批准号:
10228590 - 财政年份:2018
- 资助金额:
$ 7.86万 - 项目类别:
Project 4: Evaluating mediation effects of the microbiome and epigenetics using high dimensional assays
项目 4:使用高维分析评估微生物组和表观遗传学的中介效应
- 批准号:
10091542 - 财政年份:2013
- 资助金额:
$ 7.86万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 7.86万 - 项目类别:
Research Grant














{{item.name}}会员




